Yüklüyor......
Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report
RATIONALE: Due to the anatomical and biological characteristics of nasopharyngeal carcinoma (NPC), radiotherapy is the standard treatment of choice. Recent advances in small molecule therapies targeting tumor angiogenesis also hold promise for the treatment of advanced NPC. PATIENT CONCERNS: The pat...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344178/ https://ncbi.nlm.nih.gov/pubmed/30608382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013491 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|